Seoul: Tuesday’s trading on the Korea Stock Exchange saw varied movements in the KOSPI 200 stocks, with some companies experiencing significant gains while others faced
Seoul: Celltrion Inc., a major South Korean biopharmaceutical company, has reported an estimated third-quarter operating profit of 301 billion won (US$211.9 million), marking a 44.9
Seoul: The KOSPI 200 index displayed a mix of gains and losses among its listed companies at the market close. Standout performances included Hyundai Rotem,
Seoul: South Korea’s largest export promotion fair commenced its three-week run on Tuesday, aiming to draw global attention to Korean companies in anticipation of the
Seoul: South Korea’s exports decreased by 7.8 percent in the first 20 days of October compared to the same period last year, as indicated by
Seoul: Samsung Bioepis Co., a biopharmaceutical unit under Samsung Group, announced a collaboration with Chinese biotech firm Phrontline Biopharma to co-develop, manufacture, and commercialize antibody-drug
Seoul: South Korea’s exports experienced a 7.8 percent decrease from the previous year in the first 20 days of October, primarily due to the reduction
Seoul: A local court on Tuesday acquitted Kim Beom-su, founder of tech giant Kakao Corp., of charges of stock manipulation related to the company’s takeover